Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection
Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection
批准号:
9759740
负责人:
Santanu Bose
金额:
$37.52万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2022-07-31
关键词:
25-hydroxycholesterolAirway DiseaseBindingBronchiolitisCell surfaceCellsChildCholesterolClinicalDevelopmentDiseaseElderlyEnsureEnzymesFocal Adhesion Kinase 1HealthHumanImmunocompromised HostIn VitroIndividualInfantInfectionInflammationInflammatoryInflammatory ResponseInfluenza A virusInnate Immune ResponseIntegrinsKnockout MiceKnowledgeLifeLigandsLinkLipidsMediatingMediator of activation proteinMembraneMixed Function OxygenasesModelingMolecularMorbidity - disease rateMusNatural ImmunityPathogenesisPathway interactionsPatternPattern recognition receptorPhysiologicalPlayPneumoniaPredispositionReceptor ActivationReportingRespiratory Syncytial Virus InfectionsRespiratory SystemRespiratory Tract DiseasesRespiratory Tract InfectionsRespiratory syncytial virusRoleSeverity of illnessSignal PathwaySignal TransductionStudy modelsTLR3 geneTestingTherapeuticToll-like receptorsVirusVirus DiseasesWild Type Mouseadaptive immune responseadaptive immunityautocrinecombatextracellularhigh riskin vivomacrophagemolecular modelingmortalitynovelpathogenrespiratory infection virusrespiratory virusresponsetherapeutic developmentvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Innate immunity constitutes pro-inflammatory response to initiate inflammation for adaptive immune response
required for virus clearance. Pro-inflammatory (and inflammation) response need to be “tightly” regulated
during virus infection since exaggerated inflammation contributes to inflammatory diseases. Activation of
Pattern Recognition Receptors (PRRs) is critical for triggering innate immunity and inflammation during
infection with human respiratory syncytial virus (RSV) and influenza A virus (IAV). Therefore, it is important to
study the underlying cellular/molecular mechanism involved in transducing optimal innate immunity and
inflammatory (and pro-inflammatory) response upon PRR activation. We have surprisingly identified a novel
signaling network that is required for optimal pro-inflammatory response following PRR activation. Our
preliminary result suggested that an oxysterol (a bioactive lipid) 25-hydroxycholesterol (25HC) play an
important role in magnifying and intensifying pro-inflammatory response following activation of PRRs and
during virus (RSV, IAV) infection. Surprisingly we observed interaction of 25HC with cell surface integrins and
further preliminary studies suggested a possible mechanism. Mechanistically, we postulate that 25HC released
from PRR activated (and virus infected) cells act as an extracellular soluble mediator to activate 25HC---
integrin (51, V3 integrins)---FAK (focal adhesion kinase)---NFB pathway for optimal pro-inflammatory
response. Thus, we envision that extracellular 25HC serve as a “linker” (via autocrine/paracine mechanism) to
bridge PRR pathway with integrin pathway for optimal pro-inflammatory response. We hypothesize that - a)
extracellular 25HC links PRR pathway with integrin pathway; b) PRR---25HC---integrin---FAK---NFB signaling
network magnifies pro-inflammatory response and inflammation; and c) 25HC--- integrin---FAK signaling
pathway contributes to exaggerated inflammation during RSV and IAV infection, thus leading to development
of exacerbated airway diseases like pneumonia and bronchiolitis. In the current proposal we have selected a
membrane bound PRR (i.e. toll-like receptor 3 or TLR3) and a cytosolic PRR (i.e. Nod2) along with two
clinically important respiratory viruses (RSV, IAV) to elucidate the role of 25HC---integrin---FAK---NFB
pathway in promoting optimal and maximal pro-inflammatory response. In aim-1 we will investigate interaction
of 25HC with integrins leading to activation of integrin---FAK---NFB pathway and subsequent pro-
inflammatory response in macrophages. In aim-2 we will examine the role of 25HC---integrin---FAK---NFB
pathway in triggering optimal pro-inflammatory response in macrophages following PRR (TLR3, Nod2)
activation and virus (RSV, IAV) infection. Finally, in aim-3 we will utilize knockout mice to study physiological in
vivo role of 25HC---integrin---FAK pathway during PRR (Nod2, TLR3) activation and virus (RSV, IAV) infection.
Significance –Our current proposal has wide implication in development of therapeutics against RSV, IAV and
other pathogens that activate PRRs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome
-
批准号:8903838
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2015
-
负责人:Santanu Bose
-
依托单位:
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome
-
批准号:9001254
-
项目类别:
-
资助金额:$18.97万
-
财政年份:2015
-
负责人:Santanu Bose
-
依托单位:
Host defense against respiratory virus infections
-
批准号:8828325
-
项目类别:
-
资助金额:$6.71万
-
财政年份:2010
-
负责人:Santanu Bose
-
依托单位:
Host defense against respiratory virus infections
-
批准号:8075435
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2010
-
负责人:Santanu Bose
-
依托单位:
Host defense against respiratory virus infections
-
批准号:7793021
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2010
-
负责人:Santanu Bose
-
依托单位:
Host defense against respiratory virus infections
-
批准号:8662164
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2010
-
负责人:Santanu Bose
-
依托单位:
Host defense against respiratory virus infections
-
批准号:8279249
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2010
-
负责人:Santanu Bose
-
依托单位:
Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection
-
批准号:10190789
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2010
-
负责人:Santanu Bose
-
依托单位:
Host defense against respiratory virus infections
-
批准号:8473154
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2010
-
负责人:Santanu Bose
-
依托单位:
Oncolytic activity of respiratory syncytial virus against prostate cancer
-
批准号:7564763
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2008
-
负责人:Santanu Bose
-
依托单位:
Oncolytic activity of respiratory syncytial virus against prostate cancer
-
批准号:7470277
-
项目类别:
-
资助金额:$16.65万
-
财政年份:2008
-
负责人:Santanu Bose
-
依托单位:
Anti viral function of interferon alpha induced human beta defensin 3
-
批准号:7497050
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2007
-
负责人:Santanu Bose
-
依托单位:
Anti viral function of interferon alpha induced human beta defensin 3
-
批准号:7313427
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2007
-
负责人:Santanu Bose
-
依托单位:
DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR
-
批准号:6307905
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2000
-
负责人:Santanu Bose
-
依托单位:
DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR
-
批准号:6118860
-
项目类别:
-
资助金额:$0.31万
-
财政年份:1999
-
负责人:Santanu Bose
-
依托单位:
DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR
-
批准号:6279880
-
项目类别:
-
资助金额:$0.21万
-
财政年份:1998
-
负责人:Santanu Bose
-
依托单位:
DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR
-
批准号:6250041
-
项目类别:
-
资助金额:$1.45万
-
财政年份:1997
-
负责人:Santanu Bose
-
依托单位:
DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR: CHOLESTEROL
-
批准号:5222140
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Santanu Bose
-
依托单位:--
海外基金